Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

Yago Nieto, MD, PhD, discusses AFM13, how it works, and its effect as a bispecific antibody that targets CD30 and CD16.

After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly ...

A 25-year-old woman brushed off her symptoms for months - putting up with pain in her shoulder, an irritating cough, and ...

Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...

The patient was diagnosed with nongerminal-center B cell diffuse large B-cell lymphoma (DLBCL) 1 year after being diagnosed with primary biliary cholangitis (PBC).

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Penn-Trafford sophomore Abby Rayman and her team of fundraisers generated more than $18,000 for the Leukemia and Lymphoma Society, exceeding the $10,000 goal she set in February. A national nonprofit ...

Treatment consisted of 4-6 cycles of dose-dense intensive chemotherapy incorporating hyperfractionated cyclophosphamide/ifosfamide, high-dose cytarabine and methotrexate, doxorubicin, etoposide, ...

Ireland's first mobile pet therapy service will be opened at Regional Hospital Mullingar later today. The facility will allow ...

Memo del Bosque was diagnosed with Hodgkin’s lymphoma in 2017. This aggressive cancer primarily affects white blood cells ...